BiVO4/Fe3O4@polydopamine superparticles for tumor multimodal imaging and synergistic therapy

Ze Wang,Guan Wang,Tingting Kang,Shuwei Liu,Lu Wang,Haoyang Zou,Yu Chong,Yi Liu
DOI: https://doi.org/10.1186/s12951-021-00802-x
IF: 10.2
2021-03-29
Journal of Nanobiotechnology
Abstract:Abstract Background Despite tremendous progress has been achieved in tumor theranostic over the past decade, accurate identification and complete eradication of tumor cells remain a great challenge owing to the limitation of single imaging modality and therapeutic strategy. Results Herein, we successfully design and construct BiVO 4 /Fe 3 O 4 @polydopamine (PDA) superparticles (SPs) for computed tomography (CT)/photoacoustic (PA)/magnetic resonance (MR) multimodal imaging and radiotherapy (RT)/photothermal therapy (PTT) synergistic therapy toward oral epithelial carcinoma. On the one hand, BiVO 4 NPs endow BiVO 4 /Fe 3 O 4 @PDA SPs with impressive X-ray absorption capability due to the high X-ray attenuation coefficient of Bi, which is beneficial for their utilization as radiosensitizers for CT imaging and RT. On the other hand, Fe 3 O 4 NPs impart BiVO 4 /Fe 3 O 4 @PDA SPs with the superparamagnetic property as a T 2 -weighted contrast agent for MR imaging. Importantly, the aggregation of Fe 3 O 4 NPs in SPs and the presence of PDA shell greatly improve the photothermal conversion capability of SPs, making BiVO 4 /Fe 3 O 4 @PDA SPs as an ideal photothermal transducer for PA imaging and PTT. By integrating advantages of various imaging modalities (CT/PA/MR) and therapeutic strategies (RT/PTT), our BiVO 4 /Fe 3 O 4 @PDA SPs exhibit the sensitive multimodal imaging feature and superior synergistic therapeutic efficacy on tumors. Conclusions Since there are many kinds of building blocks with unique properties appropriating for self-assembly, our work may largely enrich the library of nanomateirals for tumor diagnosis and treatment.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?